www.fdanews.com/articles/134120-restrictions-apt-to-cut-avandia-sales

Restrictions Apt to Cut Avandia Sales

February 8, 2011

GlaxoSmithKline PLC has updated labels for its diabetes pill Avandia to include safety restrictions because of the drug’s links to heart attacks.
boston